Real life experience with mTOR-inhibitors after lung transplantation
Author:
Publisher
Elsevier BV
Subject
Pharmacology,Immunology,Immunology and Allergy
Reference13 articles.
1. Immunosuppression and allograft rejection following lung transplantation: Evidence to date;Snell;Drugs,2013
2. Immunosuppression for lung transplantation: Current and future;Chandrashekaran;Curr. Transplant Rep.,2018
3. Immunosuppression in lung transplantation;Scheffert;J. Thorac. Dis.,2014
4. Predictors of decline in renal function after lung transplantation;Barraclough;J. Heart Lung Transplant.,2006
5. A randomized trial of everolimus-based quadruple therapy vs standard triple therapy early after lung transplantation;Gottlieb;Am. J. Transplant.,2019
Cited by 9 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Association between anion gap and the 30-day mortality of patients with ventilator-associated pneumonia: a study of the MIMIC-III database;Journal of Thoracic Disease;2024-05
2. Sirolimus Long-Term Tolerability and Impact on Kidney Function in Lung Transplantation: A Single-Center Experience;Transplantation Proceedings;2023-12
3. Lymphocyte Depleting and Modulating Therapies for Chronic Lung Allograft Dysfunction;Pharmacological Reviews;2023-06-09
4. Calcineurin-inhibitor free immunosuppression after lung transplantation – a single center case-control study in 51 patients converted to Mechanistic Target of Rapamycin (mTOR) inhibitors;PLOS ONE;2023-05-18
5. Rescue Everolimus Post Lung Transplantation is Not Associated With an Increased Incidence of CLAD or CLAD-Related Mortality;Transplant International;2023-02-07
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3